AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

SACUBITRIL; VALSARTAN in Zimbabwe

9 products registered with MCAZ β€” 9 active

Brand / ProductReg. No.HolderStatusExpires
NEPRIVAS 24/26
TABLET, COATED; ORAL
2026/12.3.5/7295MSN LABORATORIES PRIVATE LIMITEDactive8 Feb 2031
NEPRIVAS 49/51
TABLET, COATED; ORAL
2026/12.3.5/7296MSN LABORATORIES PRIVATE LIMITEDactive8 Feb 2031
NEPRIVAS 97/103
TABLET, COATED; ORAL
2024/12.3.5/6795MSN LABORATORIES LTDactive12 Dec 2029
SACUVAN 97/103
TABLET, COATED; ORAL
2022/12.3.5/6344HETERO LABS LTDactive20 Nov 2028
SACUVAN 24/26
TABLET, COATED; ORAL
2022/12.3.5/6342HETERO LABS LTDactive20 Nov 2028
SACUVAN 49/51
TABLET, COATED; ORAL
2022/12.3.5/6343HETERO LABS LTDactive20 Nov 2028
UPERIO
TABLET, COATED; ORAL
2018/12.9/5722NOVARTIS PHARMA SERVICES AGactive31 Dec 2027
UPERIO
TABLET, COATED; ORAL
2018/12.9/5721NOVARTIS PHARMA SERVICES AGactive31 Dec 2027
UPERIO
TABLET, COATED; ORAL
2018/12.9/5723NOVARTIS PHARMA SERVICES AGactive31 Dec 2027

SACUBITRIL; VALSARTAN β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing SACUBITRIL; VALSARTAN, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track SACUBITRIL; VALSARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Sacubitril Valsartan β€” Zimbabwe (MCAZ) | AfricaRegulatory